Human ether-à-go-go related gene (hERG) is crucial for the coordination
of the heart's beating. Thus, if a drug blocks the hERG, it could lead to severe
adverse effects. Therefore, reliable prediction of hERG liability in the early
stages of drug design is quite important to reduce the risk of cardiotoxicity-related
attritions in the later development stages. There are three targets: hERG_at_1microM,
hERG_at_10microM, and herg_inhib.… See the full description on the dataset page: https://huggingface.co/datasets/jablonkagroup/herg_central_at_10uM.
